ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Bone marrow transplantation"

  • 2018 American Transplant Congress

    Post-Transplant High Dose Cyclophosphamide Treatment Induces Thymus-Independent Immune Tolerance of Vascularized Composite Allografts via Complete Depletion of the Alloreactive TCR Repertoire.

    G. Furtmüller,1 B. Oh,1 J. Sidhom,2 M. Fryer,1 V. Malek,1 X. Zhou,1 D. Cooney,1 C. Brayton,3 J. Dodd-o,4 S. Ganguly,2 G. Raimondi,1 W. Lee,1 L. Luznik,2 G. Brandacher.1

    1Plastic and Reconstructive Surgery, Johns Hopkins University, Baltimore, MD; 2Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD; 3Department for Comparative Pathobiology, Johns Hopkins University, Baltimore, MD; 4Department of Anesthesiology, Johns Hopkins University, Baltimore, MD.

    Background: Treatment with PT/Cy in the setting of combined donor bone marrow transplantation and VCA has shown encouraging results with regards to chimerism induction and…
  • 2018 American Transplant Congress

    CD4+CD25bright Regulatory T Cells Prevent Acute Xenogeneic GVHD

    Y. Huang, A. Merchak, H. Xu, A. Chhabra, A. Khalil, Y. Wen, M. Binion, M. Badder, L. Kahn, S. Ildstad.

    Institute for Cellular Therapeutics, University of Louisville, Louisville, KY.

    Graft-versus-host disease (GVHD) is a major complication and limitation to the broad application of hematopoietic stem cell transplantation. Cell therapy has emerged as a promising…
  • 2018 American Transplant Congress

    Low Intensity Conditioning Protocol for Inducing Chimerism-Based Tolerance in Non-Obese Diabetic Mice

    A. Chhabra, Y. Huang, H. Xu, A. Merchak, S. Ildstad.

    Institute for Cellular Therapeutics, University of Louisville, Louisville, KY.

    Type 1 diabetes is the most common chronic disease affecting children. Islet cell or pancreas transplantation offer the most physiologic approach to glucose homostasis. However…
  • 2018 American Transplant Congress

    Outcomes after Kidney Transplantation in Patients with AL Amyloid Following Autologous Stem Cell Transplantation

    V. Gutgarts,1,2 I. Jaffer Sathick,2 C. Rosenbaum,3 T. Muthukumar,1 H. Hassoun,4 C. Flombaum,2 H. Landau.4

    1Nephrology, Weill Cornell, NY; 2Renal Medicine, Memorial Sloan Kettering, NY; 3Hematology, Weill Cornell, NY; 4Hematology, Memorial Sloan Kettering, NY.

    BackgroundAL amyloidosis results in kidney failure in about 15-30% of patients and is considered a relative contraindication for kidney transplantation. There is limited data on…
  • 2018 American Transplant Congress

    A Novel Protocol to Improve Kidney Transplant Outcomes in Patients with Renal Disease Due to Amyloidosis

    A. Langone, B. Concepcion, D. Slosky, R. Cornell, S. Horst, S. Goodman.

    Vanderbilt University Medical Center, Nashville, TN.

    In 2011, members from 10 different medical disciplines formed the Vanderbilt Amyloid Multidisciplinary Program (VAMP) in an effort to improve regional recognition of this rare…
  • 2018 American Transplant Congress

    Building a Third-Party VST Bank from Scratch- The Cincinnati Experience

    A. S. Nelson,1 D. Heyenbruch,2 X. Zhu,3 S. M. Davies,1 C. Lutzko,3 C. Bollard,4 P. Hanley,4 T. Leemhuis,2 L. Danziger-Isakov,5 M. S. Grimley.1

    1Bone Marrow Transplant & Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; 2Hoxworth Blood Center, Univeristy of Cincinnati, Cincinnati, OH; 3Experimental Hematology & Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; 4Proram for Cell Enhancement and Technologies for Immunotherapy, Children's National Health System, Washington, DC; 5Depatment of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

    BackgroundViral infections remain a challenge to treat and significantly contribute to morbidity and mortality. Virus specific T cells (VSTs) have shown clinical efficacy, with minimal…
  • 2018 American Transplant Congress

    RNA Expression Profiling of Renal Allografts in a Non-Human Primate Identifies Inflammation as a Risk Factor in Chronic Antibody Mediated Rejection

    R. Smith,1 B. Adam,2 A. Rosales,1 M. Matsunami,3 T. Oura,3 B. Cosimi,3 T. Kawai,3 M. Mengel,2 R. Colviin.1

    1Pathology, Massachusetts General Hospital, Boston, MA; 2Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada; 3Surgery, Massachusetts General Hospital, Boston, MA.

    IntroductionChronic alloantibody mediated rejection (CAMR) is a major risk factor in renal allografts. Some inflammation is commonly identified within CAMR, though mostly low grade, and…
  • 2018 American Transplant Congress

    RNA Expression Profiling of Renal Allografts in the Cynomolgus Monkey Identifies Tolerance

    R. Smith,1 M. Matsunami,3 B. Adam,2 A. Rosales,1 T. Oura,3 A. Cosimi,3 T. Kawai,3 M. Mengel,2 R. Colvin.1

    1Pathology, Massachusetts General Hospital, Boston, MA; 2Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada; 3Department of Surgery, Massachusetts General Hospital, Boston, MA.

    IntroductionTolerance induction is a long standing clinical goal. However, identification remains elusive. Here we profile intra-renal allograft RNA expression in a mixed chimerism renal allograft…
  • 2018 American Transplant Congress

    Relationship between Mixed Chimerism and Acceptance of HLA-Matched and Mismatched Kidney Transplants after Withdrawal of Immunosuppressive Drugs

    J. Scandling, S. Busque, R. Lowsky, J. Shizuru, K. Jensen, A. Shori, E. Engleman, E. Meyer, R. Hoppe, S. Strober.

    Stanford University, Stanford, CA.

    Classical studies in cattle and rodents showed that mixed chimerism (MXC) established in fetuses and neonates was permanent, linked to immune tolerance and graft acceptance…
  • 2018 American Transplant Congress

    Long-Term Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients

    J. Leventhal,1 J. Galvin,1 J. Mathew,1 L. Gallon,1 D. Stare,1 K. Kurtenbach,1 K. Ravindra,3 M. Horwitz,3 J. Miller,1 M. Abecassis,1 S. Ildstad.2

    1Surgery, Northwestern U, Chicago; 2U of Louisville, Louisville; 3Duke U, Durham.

    37 pts have been transplanted in a phase 2 protocol to induce tolerance in recipients of living donor renal allografts (KTx). The protocol is based…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 9
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences